Dr. Tzubery is a seasoned academic and industrial researcher with over 10 years' experience in the diagnostics and medical device industries. Dr. Tzubery completed his doctoral, master's and undergraduate studies at the Hebrew University of Jerusalem, where he earned a Ph.D. in biochemistry, a M.Sc. in biotechnology and a B.S. in agricultural sciences. Before joining Neurogenic, Dr Tzubery was the R&D Project Manager at Novamed Ltd. and R&D Director at Syntezza Molecular Detection Ltd. He is currently leading the commercialization of the schizophrenia ELISA test.